Evidence map›Paper›PMID 36319792›Full record

ReviewApplied microbiology and biotechnology2022

Structures, biosynthesis, and bioactivities of prodiginine natural products.

Peishan Li, Shufen He, Xuejiao Zhang, Qi Gao, Yanan Liu, Liwei Liu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Applied microbiology and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. High-level prodigiosin production inSynthetic and systems biotechnology · 2026
    Article
  4. Metacycloprodigiosin produced by a high-yieldOrganic & biomolecular chemistry · 2026
    Article
  5. Review
  6. Promising Prodiginins Biological Activities.Chemistry & biodiversity · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Functionalization of silk with actinomycins fromFrontiers in bioengineering and biotechnology · 2024
    Article
  13. Review
  14. Prodigiosin-ProducingFoods (Basel, Switzerland) · 2023
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Peishan Li *Department of Marine Pharmacy, College of Food and Pharmaceutical Sciences, Li Dak Sum Marine Biopharmaceutical Research Center, Ningbo University, Ningbo, 315832, Zhejiang, China.
Shufen He *Department of Marine Pharmacy, College of Food and Pharmaceutical Sciences, Li Dak Sum Marine Biopharmaceutical Research Center, Ningbo University, Ningbo, 315832, Zhejiang, China.
Xuejiao ZhangKey Laboratory of Pollution Ecology and Environmental Engineering, Institute of Applied Ecology, Chinese Academy of Sciences, Shenyang, 110016, China.
Qi GaoDepartment of Food Science and Engineering, College of Food and Pharmaceutical Sciences, Ningbo University, Ningbo, 315211, People's Republic of China.
Yanan LiuDepartment of Food Science and Engineering, College of Food and Pharmaceutical Sciences, Ningbo University, Ningbo, 315211, People's Republic of China.
Liwei LiuDepartment of Marine Pharmacy, College of Food and Pharmaceutical Sciences, Li Dak Sum Marine Biopharmaceutical Research Center, Ningbo University, Ningbo, 315832, Zhejiang, China. liuliwei@nbu.edu.cn.ORCID http://orcid.org/0000-0002-0578-1091
Ningbo University · CNChinese Academy of Sciences · CN

Funding

General scientific research projects of Zhejiang Provincial Education Department Y202043824Ningbo Key Science and Technology Development Program 2021Z046Ningbo University 422010882Ningbo University 422110473Ningbo University 422207513the State Key Laboratory of Natural and Biomimetic Drugs K202006
6 · The paper itself

Abstract

Prodiginines are a large family of microbial secondary metabolites with a core structure of tripyrrole rings. They exhibit not only diverse chemical structures but also rich biological activities, such as anti-cancer, anti-microbial, anti-algae, anti-parasitic, pesticides, and UV radiation resistance. The preferred cytotoxicity to cancer cells rather than normal cells indicates a good biological selectivity and safety, which makes the prodiginines promising candidates for drug development and novel additives for food processing. Until now, 33 prodiginine natural products have been identified in various bacteria, including Serratia, Hahella, Pseudoalteromonas, Vibrio, Zooshikella, Streptomyces, and Actinomadura. However, most efforts are still focused on the star molecule prodigiosin, while little yet is known about other prodiginine members, which retards the research and application of prodiginine compounds. To gain insight into the prodiginine family, we reviewed the recent discoveries on their chemical structures, biosynthesis, biological activities, and mechanisms of action. We believe this article will provide a guideline for new research on prodiginines, such as the discovery of new congeners and drug development. KEY POINTS: • The prodiginines are a large family of natural products with a core structure of tripyrrole rings and exhibit various bioactivities. • The prodiginines have a widespread distribution among many environmental microbes and diverse biosynthetic pathways, indicating important ecological roles and a great potential for new congeners. • The potent biological activities and good selectivity of action make prodiginines good lead compounds for drug development.

Indexed as

Biological ProductsStreptomycesProdigiosinSerratiaBiological ProductsprodiginineProdigiosinBiological activityBiosynthesisChemical structureMicrobial natural productProdiginine

Identifiers

PMID36319792
OpenAlexW4307973819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.